Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Top stocks for August

    | The Motley Fool Staff

    We asked our analysts to share their top stock picks for the coming month.

    Read more »

    Investing Articles

    AstraZeneca plc’s shock plunge is a buying opportunity for the brave

    | Harvey Jones

    This could be the moment to buy AstraZeneca plc (LON: AZN) that you have been waiting for, says Harvey Jones.

    Read more »

    Investing Articles

    Is AstraZeneca plc a falling knife to catch after dropping 15% today?

    | Alan Oscroft

    AstraZeneca plc (LON: AZN) could be one of best bargains of the FTSE 100 (INDEXFTSE: UKX) right now.

    Read more »

    Investing Articles

    Why I’m considering FTSE 100 income and growth champion AstraZeneca plc

    | Rupert Hargreaves

    AstraZeneca plc (LSE: AZN) looks attractive to me today.

    Read more »

    Investing Articles

    2 FTSE 100 stocks for retirement income AND growth

    | G A Chester

    These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver above-average income and strong capital growth.

    Read more »

    Investing Articles

    2 FTSE 100 dividend stocks I’d buy in May

    | Roland Head

    Roland Head highlights two stocks with the potential for long-term income growth.

    Read more »

    Investing Articles

    Does cancer breakthrough make this stock a better buy than AstraZenenca plc?

    | Bilaal Mohamed

    Should investors ditch AstraZeneca plc (LON:AZN) in favour of this promising AIM-listed biotech firm?

    Read more »

    Investing Articles

    2 ‘evergreen’ Neil Woodford picks I’d buy now

    | Kevin Godbold

    These two stalwarts could power your portfolio for years to come.

    Read more »

    Investing Articles

    2 FTSE 100 growth giants that could fund your retirement

    | Alan Oscroft

    These two rising FTSE 100 (INDEXFTSE:UKX) stocks could help you to a comfortable old age.

    Read more »

    Investing Articles

    1 FTSE 100 stock I’d buy in April, and 1 I’d avoid

    | Alan Oscroft

    I'd rate these two as one of the best and one of the worst in the FTSE 100 (INDEXFTSE:UKX).

    Read more »

    Investing Articles

    2 Neil Woodford stocks I’d buy in an instant

    | Peter Stephens

    These two Neil Woodford stocks could deliver high returns.

    Read more »

    Investing Articles

    Is this top FTSE 100 income stock a clear takeover candidate?

    | Rupert Hargreaves

    Could this company find itself a takeover target once again?

    Read more »